210
Views
2
CrossRef citations to date
0
Altmetric
special report

Vapor for lung volume reduction; pros and cons

, ORCID Icon, , , , , , , , & show all
Pages 1189-1195 | Received 19 Apr 2020, Accepted 26 Aug 2020, Published online: 24 Sep 2020

References

  • van der Molen T, Kirenga BJ. COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract. 2015;69(5):513–514.
  • Berger RL, Decamp MM, Criner GJ, et al. Lung volume reduction therapies for advanced emphysema: an update. Chest. 2010;138(2):407–417.
  • Ingenito EP, Berger RL, Henderson AC, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med. 2003;167(5):771–778.
  • Refaely Y, Dransfield M, Kramer MR, et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. Eur Respir J. 2010;36(1):20–27.
  • Shah PL, Gompelmann D, Valipour A, et al. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med. 2016;4(9):e44–e45.
  • Sciurba FC, Criner GJ, Strange C, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. Jama. 2016;315(20):2178–2189.
  • Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thorac Cardiovasc Surg. 2007;134(4):974–981.
  • Weinmann GG, Chiang YP, Sheingold S. The National Emphysema Treatment Trial (NETT): a study in agency collaboration. Proc Am Thorac Soc. 2008;5(4):381–384.
  • Lee SM, Wise R, Sternberg AL, et al. National emphysema treatment trial research G. Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trial. Clin Trial. 2004;1(3):326–338.
  • Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012;39(6):1326–1333.
  • Snell GI, Hopkins P, Westall G, et al. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg. 2009;88(6):1993–1998.
  • Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
  • ZEPHYR. (Ed.^(Eds)
  • Garner JL, Shah PL Lung volume reduction in pulmonary emphysema. Seminars in respiratory and critical care medicine, (2020).
  • Franzen D, Straub G, Steinack C. Bronchoscopic thermal vapor ablation after unsuccessful lung volume reduction surgery: A case report. Respir Med Case Rep. 2020;30:101048.
  • Xu W, Wang J, He X, et al. Bronchoscopic lung volume reduction procedures for emphysema: A network meta-analysis. Medicine (Baltimore). 2020;99(5):e18936.
  • Milenkovic B, Janjic SD, Popevic S. Review of lung sealant technologies for lung volume reduction in pulmonary disease. Med Devices. 2018;11:225–231.
  • Spotnitz WD. Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective. ISRN Surg. 2014;203943:2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.